PapersPMID:36319585
Efficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 5 days
- Dose studied, every finding
- 500 mg capsule every 12 hours for 5 days (intervention B)
What moved
How to read these marks →“Additionally, the length of hospitalization for intervention group A (MD=1.75, P<0.001) and intervention group B (MD=1.66, P<0.001) were significantly shorter than the control group.”
- Population
- Hospitalised adults aged 18 to 72 with PCR-confirmed COVID-19 pneumonia, Tehran, Iran; 500 mg arm; all three arms also received dexamethasone, remdesivir, heparin and supplemental oxygen
“Furthermore, ESR (MD=14.79, P<0.001) and CRP (MD=16.28, P<0.001) of intervention B were significantly lower than the control group; however, other laboratory tests did not differ (P>0.05).”
- Population
- Hospitalised adults aged 18 to 72 with PCR-confirmed COVID-19 pneumonia, Tehran, Iran; day 5 of hospitalisation, 500 mg arm; all three arms also received dexamethasone, remdesivir, heparin and supplemental oxygen
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Hospitalized COVID-19 patients aged 18 to 72 years with PCR-confirmed infection, infectious diseases ward, Labbafinejad Hospital, Tehran, Iran; all received standard COVID-19 treatment
- Participants
- 141
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 22